Company ESSA Pharma Inc Toronto S.E.
Equities
EPI
CA29668H1047
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
David Wood
DFI | Director of Finance/CFO | 66 | 13-09-30 |
Peter Virsik
COO | Chief Operating Officer | - | 16-07-31 |
Chief Tech/Sci/R&D Officer | 63 | 19-07-14 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Franklin Berger
BRD | Director/Board Member | 74 | 15-03-04 |
Sanford Zweifach
BRD | Director/Board Member | 68 | 19-07-30 |
Richard Glickman
CHM | Chairman | 65 | 10-09-30 |
Director/Board Member | 55 | 19-07-30 | |
Scott Requadt
BRD | Director/Board Member | 56 | 16-01-13 |
David Parkinson
CEO | Chief Executive Officer | 73 | 15-06-23 |
Philip Kantoff
BRD | Director/Board Member | 69 | 22-09-12 |
Ann Thorell
BRD | Director/Board Member | 56 | 19-07-30 |
Gary Sollis
BRD | Director/Board Member | 69 | 12-04-25 |
Lauren Merendino
BRD | Director/Board Member | 49 | 23-06-05 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 44,238,147 | 43,230,993 ( 97.72 %) | 0 | 97.72 % |
Company contact information
Sector
1st Jan change | Capi. | |
---|---|---|
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |